Evidence map›Paper›PMID 38662264›Full record

ArticleFamilial cancer2024

Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review.

Agani Afaya, Sung-Won Kim, Hyung Seok Park, Myong Cheol Lim, Mi Sook Jung, Eun Ji Nam, Ji Soo Park, Joon Jeong, Jai Min Ryu, JiSun Kim and 9 more

Abstract readScoping Review
PubMed Publisher
In one paragraph

Article in Familial cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. A scalable new model of germline cancer genomic care delivery: Assessing psychological outcomes.Genetics in medicine : official journal of the American College of Medical Genetics · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 4 countries.

Agani AfayaCollege of Nursing, Yonsei University, Seoul, Korea.ORCID 0000-0002-7918-2999
Sung-Won KimDepartment of Breast Surgery, Breast Care Center, Dairim St. Mary's Hospital, Seoul, Korea.
Hyung Seok ParkDepartment of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Myong Cheol LimDivision of Tumor Immunology, Center for Gynecologic Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Mi Sook JungCollege of Nursing, Chungnam National University, Daejeon, Korea.
Eun Ji NamDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Korea.
Ji Soo ParkHereditary Cancer Clinic, Cancer Prevention Center, Yonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Joon JeongDepartment of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Jai Min RyuDivision of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
JiSun KimDepartment of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Jihye KimCollege of Nursing, Yonsei University, Seoul, Korea.
Minkyoung KimCollege of Nursing, Yonsei University, Seoul, Korea.
Juhye JinDepartment of Nursing, Korea National University of Transportation, Jeungpyeong, Korea.
Jeehee HanRed Cross College of Nursing, Chung-Ang University, Seoul, Korea.
Soo Yeon KimCollege of Nursing, Yonsei University, Seoul, Korea.
Sun-Young ParkCollege of Nursing, Daegu Catholic University, Daegu, South Korea.
Maria C KatapodiDepartment of Clinical Research, University of Basel, Basel, Switzerland.ORCID 0000-0003-3903-3750
Sue KimCollege of Nursing, Mo-Im Kim Nursing Research Institute, Yonsei University, Seoul, Korea. suekim@yuhs.ac.ORCID 0000-0003-3785-2445
K-CASCADE consortium
Yonsei University · KRUlsan College · KRChung-Ang University · KRChungnam National University · KRDaegu Catholic University · KRKorea National University of Transportation · KRNational Cancer Center · KRSamsung Medical Center · KRUniversity of Basel · CH

Funding

National Research Foundation of Korea 2019K1A3A1A14063080
6 · The paper itself

Abstract

Despite increased awareness and availability of genetic testing for hereditary breast and ovarian cancer (HBOC) syndrome for over 20 years, there is still significant underuse of cascade genetic testing among at-risk relatives. This scoping review synthesized evidence regarding psychosocial barriers and facilitators of family communication and/or uptake of cascade genetic testing in relatives from HBOC families. Search terms included 'hereditary breast and ovarian cancer' and 'cascade genetic testing' for studies published from 2012-2022. Through searching common databases, and manual search of references, 480 studies were identified after excluding duplications. Each article was reviewed by two researchers independently and 20 studies were included in the final analysis. CASP, RoBANS 2.0, RoB 2.0, and MMAT were used to assess the quality of included studies. A convergent data synthesis method was used to integrate evidence from quantitative and narrative data into categories and subcategories. Evidence points to 3 categories and 12 subcategories of psychosocial barriers and facilitators for cascade testing: (1) facilitators (belief in health protection and prevention; family closeness; decisional empowerment; family support, sense of responsibility; self-efficacy; supportive health professionals); (2) bidirectional concepts (information; perception of genetic/cancer consequences; negative emotions and attitude); and (3) barriers (negative reactions from family and negative family dynamics). Healthcare providers need to systematically evaluate these psychosocial factors, strengthen facilitators and alleviate barriers to promote informed decision-making for communication of genetic test results and uptake of genetic testing. Bidirectional factors merit special consideration and tailored approaches, as they can potentially have a positive or negative influence on family communication and uptake of genetic testing.

Indexed as

Genetic Predisposition to DiseaseGenetic TestingBreast NeoplasmsFamilyFemaleHereditary Breast and Ovarian Cancer SyndromeHumansOvarian NeoplasmsBRCA1BRCA2CancerGenetic testingHBOCOncologyPsychooncology

Identifiers

PMID38662264
OpenAlexW4395453352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.